FindMyKOL
Clinical trialNCT02938923CompletedPhase 3Interventional

Starting a Testosterone and Exercise Program After Hip Injury

SponsorWashington University School of MedicineEnrollment129FrailtyHip FractureSarcopenia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a randomized controlled double-blinded multi-center clinical trial enrolling female hip fracture patients who are 65 and older. It will compare the effects of six months of supervised exercise training combined with daily topical testosterone gel, to six months of supervised exercise and inactive gel, and to Enhanced Usual Care. The randomization protocol is that for every nine participants randomized, 4 will be assigned to the topical testosterone gel and supervised exercise training group; 4 will be assigned to topical inactive gel and supervised exercise training group; and 1 will be assigned to the enhanced usual care group. All participants will receive nutritional counseling, and calcium and vitamin D supplements.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado, Denver

    Aurora, Colorado, United States

  • University of Connecticut Heath - Uconn Health

    Farmington, Connecticut, United States

  • University of Maryland School of Medicine/johns Hopkins University

    Baltimore, Maryland, United States

  • Hebrewsenior Life Harvard Medical School

    Roslindale, Massachusetts, United States

  • Washington University School of Medicine in St. Louis

    St Louis, Missouri, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • University of Texas Medical Branch at Galveston (utmb)

    Galveston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo gelTestosterone →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Mar 2019
Primary completion
31 Aug 2023
Completion
6 Nov 2023
Last update posted
4 Feb 2025
Registered enrollment
129
Registry id
NCT02938923

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.